Qidan Xiaoke Granules + Standard Medical Therapy for coronary artery disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Jun 2026: Trial registered, NCT07616544

The trials

NCT07616544: Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization

State
Not started
Phase
Phase 3
People
164 planned
Started
1 Jul 2026
Primary completion
30 Jun 2028
Arms
Experimental Group
Results
None posted
  1. 1 Jun 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.